|Articles|April 1, 2016
- Pharmaceutical Executive-04-01-2016
- Volume 36
- Issue 4
Pharmaceutical Executive, April 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Closing the Gaps in Drug Chain of Custodyalmost 10 years ago
Data Unleashed: Cooperation Among Competitorsalmost 10 years ago
Raising the Stakes On Value-Based Pricingalmost 10 years ago
The Diversity Dearth in Pharmaabout 10 years ago
Information in Action: A Conversation with Barbara Lopez Kunzabout 10 years ago
R&D Model Mixes Compassion, Calculationabout 10 years ago
Pressure Builds to Revamp Off-Label Marketing Rulesabout 10 years ago
Drug Compounding: A Cause and Cure for High Drug Prices?about 10 years ago
The Odd Coupleabout 10 years ago
Country Report: EgyptNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
5